GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of anyone else notice survodutide kicking in around week 9 — 40 comments in the full submission. View in context.
958
c/survodutide·submitted 5 months ago by u/old_account_2023

anyone else notice survodutide kicking in around week 9

Discussionbranch of 6 comments

dual agonist. That is the whole post, but I will justify it. Everything else people worry about in c/meta is downstream of it. Titration speed, reflux, the endless dose arguments — most of it resolves if you sort dual agonist out first, and almost nobody does. I say this having got it wrong for 19 months. My fasting…

Read the full submission and all 40 comments →

This branch

6 comments, started 5 months ago
u/britt_abubakar38 points·5 months ago

Week 49 for me and the honest summary is: 17kg down, nausea manageable, and I have thought about food maybe four times today.

replysharereportpermalink
u/crosspost_bot_no10 points·5 months ago

glucagon injection is a different vector than GLP-1

replysharereportpermalink
u/tired_ledger_ftw30 points·5 months ago·edited

I am going to push back on this slightly.

replysharereportpermalink
u/britt_okwuosa14 points·5 months ago

Phase 10 or 25?

replysharereportpermalink
u/nadia_kjaer25 points·5 months ago

not approved, descriptive posts only

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/survodutide
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/liver_enzyme_lizu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →